Envision Pharma Group, a technology solutions provider, has launched 4Sight, a novel AI technology designed to assist the life sciences industry in optimising its technology performance.
AI technology specialised for the life sciences industry
Powered by OKRA.ai and Envisions proprietary technology, it offers a strategy that can empower teams to achieve in medical affairs. According to Envision, 4Sight adopts a “holistic solution to optimise your efforts”.
Even the most advanced tools and platforms can be inhibited by user compliance and operation, so Envision has pledged to offer the appropriate training, resources and recommended operating procedures to help companies unlock the full potential for their data and insights.
Executive President and Chief Commercial Officer at Envision, Dominic Marasco said: “The life sciences sector is suffering from a fear of making the wrong decisions in tech-enablement right now. With significant groundswell in all things AI, companies are trying to balance choosing the right path forward and not being left behind, while navigating a landscape that feels unfamiliar to them.”
While a majority of businesses now have access to AI technology, a majority of the available services are not optimised for use in the life sciences, so Envision wanted to fill this niche.
Dominic adds: “With more than 20 years of industry experience, we aim to help the life sciences industry with best-in-class AI platform launches using our 4Sight approach. The 4Sight offering includes using OKRA.ai’s AI platform, an AI solution that compiles healthcare data from multiple sources – covering hundreds of therapeutic areas, thousands of clinical trials and publications.”
